MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202647090937 A) filed by Vetmab Biosciences, Inc. on July 27, 2026, for Fcrn Antagonists For Veterinary Use.
Inventors include Zhan, Hangjun; Longpre, Kristy; and Bevers, Denise.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present application relates to canine and feline FcRn antagonists comprising canine or feline Fc fragment polypeptides that reduce or block binding of canine or feline FcRn to canine or feline IgG autoantibodies, and the use of these FcRn antagonists in treating canine or feline subjects suffering from autoantibody associated autoimmune disorders, such as pemphigus, bullous pemphigoid, lupus erythematosus, and stomatitis.
Disclaimer: Curated by HT Syndication.
